2型糖尿病临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 2型糖尿病（国际通用名 type 2 diabetes）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖二型糖尿病、糖尿病、血糖高等说法。

正在招募的2型糖尿病新药试验

• A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

  I 期 / II 期招募中美国NCT07061574

• Evaluation of the Metabolic Surgery Technique for Glycemic Improvement in Type 2 Diabetes

  不适用招募中法国NCT06600555

• The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults

  不适用招募中美国NCT03761446

• Effect of Nutrition Education Groups in the Treatment of Patients with Type 2 Diabetes

  不适用招募中BrazilNCT05598203

• PILI 'Āina Household

  不适用招募中美国NCT06526273

• Feasibility Study to Evaluate an Intravascular Blood Continuous Glucose Sensor

  不适用招募中BrazilNCT06764069

• Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes

  IV 期招募中中国NCT07558863

• Manganese-enhanced Magnetic Resonance Imaging (MEMRI) in Heart Failure With Preserved Ejection Fraction

  不适用招募中英国NCT06652763

• Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study

  IV 期招募中AfghanistanKenyaNigeriaPakistanNCT05164263

• Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes

  不适用招募中美国NCT04791371

• A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants

  I 期招募中美国NCT07723833

• Pharmacogenetics of Response to GLP1R Agonists

  I 期招募中美国NCT05071898